8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-17-020173
Shareholder vote results · Other events
- Item 5.07 Submission of matters to a vote of security holders
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading v464146_8k.htm…